Three New Targets Found for Cancer Vaccines
Ludwig Cancer ResearchInvestigators at the Ludwig Institute for Cancer Research have discovered three new genes that may prompt the immune system to seek out and destroy cancer cells.
Investigators at the Ludwig Institute for Cancer Research have discovered three new genes that may prompt the immune system to seek out and destroy cancer cells.
Phase I study suggests that a protein-based vaccine may safely activate anti-cancer defenses.
Researchers discovered that chromosome 21 contains 10% more genes than earlier sequence efforts found, suggesting that if predictions on the smallest and most thoroughly analyzed chromosome are wrong, than humans have more genes than the favored 30,000 estimate.
Study suggests that current DNA chips need improvement to fully understand how genes work.
Study in mice suggests that blocking one signaling pathway may help against autoimmune disease, transplant rejection, and leukemia.
In a step that might eventually make colon cancer easier to detect and treat, a study finds that the immune system naturally identifies the hallmark signs of this cancer.
A novel video technique exposes an unnoticed pathway that allows dormant immune cells to become active again, providing new insights on how the immune system might be harnessed to fight disease.
A protein that hinders tumor fighting genes may be the key to new treatments for cancer.
Brazilian researchers decipher genetic clues that may spell the end of a pest that threatens Californian wine.
A study explains how cells crucial to the body's defense system can stimulate an immune response, raising new possibilities for their use in cancer vaccines.